搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按时间排序
按相关度排序
Daily
4 小时
Brain study challenges long-held views about Parkinson's movement disorders
University of Arizona researchers have revealed new insights into one of the most common complications faced by Parkinson's ...
Too Old to Operate
7 小时
Reliability and Validity of NoMoFA Scale for Non-Motor Fluctuations in PD
The following is a summary of “Expanded and independent validation of the NoMoFA scale for Parkinson’s disease: the Italian ...
Knowridge
19 小时
Study finds big cause of uncontrollable movements in Parkinson’s disease
Researchers at the University of Arizona have shed light on a common and troubling side effect of long-term Parkinson’s ...
GEN
20 小时
Ketamine Reduces L-DOPA-Related Uncontrolled Movements in Parkinson’s Rat Model
Rodent study indicates that the motor cortex becomes disconnected during episodes of involuntary and uncontrollable movements ...
KJZZ
1 天
UA study may open the door for ketamine to ease side effects of Parkinson's drug
In a new study, researchers from the University of Arizona looked into some of the complications experienced by people with ...
Too Old to Operate
1 天
Interrelations of Motor Complications, Anxiety, and Pain in PD
The following is a summary of “Pain in Parkinson's disease is impacted by motor complications, anxiety and sleep disturbances ...
1 天
Experts learn Parkinson's side-effect could be treated with ketamine in new research
Parkinson's patients who experience uncontrollable spasms could be treated with a course of ketamine, researchers have found ...
Neuroscience News
4 天
Ketamine Offers Hope for Parkinson’s Treatment-Linked Dyskinesia
Researchers have uncovered a new understanding of levodopa-induced dyskinesia, a common side effect in Parkinson’s patients, ...
technologynetworks
4 天
Ketamine Restores Movement Control in Parkinson’s Patients
University of Arizona researchers uncovered how levodopa-induced dyskinesia disrupts motor cortex function in Parkinson’s ...
Pharmaceutical Technology
8 天
Pridopidine hydrochloride by Prilenia Therapeutics Development for Demyelinating Diseases ...
Pridopidine hydrochloride is under clinical development by Prilenia Therapeutics Development and currently in Phase I for Demyelinating Diseases.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈